Vaccine safety surveillance across the globe with a focus on the COVID-19 vaccines

  • Arunima Sen MMS Holding Inc., Bangalore, India
Keywords: CDC, AEIS, BEST, COVID-19, COWIN

Author Biography

Arunima Sen, MMS Holding Inc., Bangalore, India

Director, Pharmacovigilance and Medical Writing.

References

Arlett, P. (2021). Safety monitoring of COVID-19 Vaccines, European medicines agency, 2021, 1-10.

FDA, Covid-19 Vaccine Safety Surveillance. Safety & Availability (Biologics), 2021; Accessed on July 12, 2021.

Joshi, J., Das, M. K., Polpakara, D., Aneja, S., Agarwal, M., & Arora, N. K. (2018). Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India. Indian journal of pediatrics, 85(2), 139–148.

Salman O, Topf K, Chandler R, Conklin L. (2021). Progress in Immunization Safety Monitoring — Worldwide, 2010–2019. MMWR Morb Mortal Wkly Rep,70, 547–551. Retrieved from https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/index.html

TGA (2021). Covid-19 Vaccine Safety monitoring plan. Australian Government, 1, 1-13.

Vaccine Centre, London School of Hygiene & Tropical Medicine, Retrieved from https://vaclshtm.shinyapps.io/ncov_vaccine_landscape/

Published
2021-09-01
How to Cite
1.
Sen A. Vaccine safety surveillance across the globe with a focus on the COVID-19 vaccines. jpadr [Internet]. 2021Sep.1 [cited 2022Nov.26];2(3):1-. Available from: https://jpadr.com/index.php/jpadr/article/view/50